Damages are being sought in the litigation. NPCT is agressively proceeding to buy out HC and remove remaining and vested shares from entering the market. Negotiations are stated to continue and that they are sensitive. Multiple testing has been stated to be in process. Numerous top notch companies have been mentioned in interviews that are involved with NPCT such as IBM, Phillips, Motorola, Infineon, Orga, Gemplus, etc.
Revenue is alluded to and has been alluded to for over a year.
Refer to previous funding items for list of funding activities. With no additional revenue and financing, reserves are addequate for up to two years. Multiple conjectured short positions have been working against the share price of NPCT from April to December 2000. All indications are that NCS is superior but this must be determined by individual company tests. They have announced steady developments.